Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America
Linda MD PhD MBA Liau (toim.) · Elsevier - Health Sciences Division · 2021

Linda MD PhD MBA Liau (toim.) · Elsevier - Health Sciences Division · 2021
This issue of Neurosurgery Clinics, guest edited by Dr. Linda M. Liau, is dedicated to Glioblastoma: Molecular and Clinical Trials. This issue is one of four selected each year by the series consulting editors, Drs. Russell R. Lonser and Daniel K. Resnick. Topics will include-but are not limited to-Pathology & Molecular Markers, Cellular States & Genetic Diversity in Glioblastoma, Mismatch Repair in Glioblastoma Resistance, Genetic Susceptibility in Brain Cancer, Pediatric Gliomas: Molecular Landscape & Emerging Targets, Molecularly Targeted Clinical Trials, Novel Radiation Sensitizers, Immunotherapy Checkpoint Inhibitors, Brain Tumor Vaccines, CAR T Cells, Oncolytic Virotherapy, Targeting Cancer Stem Cells, Therapeutic Delivery to CNS, Theranostics: Dual Modality PET Tracers, and Neuroimaging & Novel Response Assessments.
Uus kasutamata raamat
Detailid
- Autor
- Linda MD PhD MBA Liau (toim.)
- ISBN
- 9780323813051
- Aasta
- 2021
- Kirjastus
- Elsevier - Health Sciences Division
- Keel
- inglise
- Köide
- Kõva kaas
- Lehekülgi
- 240
- Kaal
- 514 g